Table III.
Number of women | QTc +/− SD | p-value* | p-value** | |
---|---|---|---|---|
| ||||
OC generation | ||||
First | 15, 719 | 400.8 +/− 21.5 | p<0.0001 | p<0.0001 |
Second | 9,303 | 399.2 +/− 21.0 | ||
Third | 5,762 | 400.8 +/− 21.1 | ||
Fourth | 3,890 | 403.5 +/− 22.6 | ||
Non-users | 376,106 | 403.5 +/− 22.6 | ||
| ||||
OC Dose | ||||
Very Low | 571 | 402.0 +/− 21.1 | p<0.0001 | 0.1866 |
Low | 33,747 | 400.7 +/− 21.3 | ||
Moderate | 157 | 402.7 +/− 20.8 | ||
Non-users | 376,106 | 403.5 +/− 22.6 | ||
| ||||
Route | ||||
Oral | 34,118 | 400.7 +/− 21.3 | p<0.0001 | 0.4942 |
Transdermal | 360 | 401.3 +/− 21.4 | ||
Vaginal | 198 | 402.4 +/− 23.8 | ||
Non-users | 376,106 | 403.5 +/− 22.6 |
OC = oral contraceptive use, QTc = corrected QT,
Includes women not on OC (OC non-users) in analysis,
Includes only women on OC in analysis